Hormone profiles and their relation with menstrual cycles in patients undergoing hemodialysis

dc.contributor.authorArıkan, Deniz Cemgil
dc.contributor.authorBozkurt, Serpil
dc.contributor.authorArıkan, İlker
dc.contributor.authorTurgut, Emre
dc.date.accessioned2024-07-12T21:11:49Z
dc.date.available2024-07-12T21:11:49Z
dc.date.issued2011en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractObjective: To investigate the etiology of menstrual disorders among patients undergoing hemodialysis due to chronic renal failure by assessing menstrual history, serum hormone levels and other biochemical factors. Material and methods: Thirty patients undergoing hemodialysis and 30 healthy women at reproductive age were enrolled in our study. Demographic characteristics, hormonal and biochemical data, sonographically measured endometrial thickness values of the subjects were compared. In addition, the present and the pre-hemodialysis menstrual pattern of the patients undergoing hemodialysis were recorded. The hormonal, hematological and biochemical data of the patients were compared according to their menstrual patterns. Results: No statistical significance was seen between age, BMI, gravida, parity, abortion and curettage among groups (p>0.05). Hemoglobin and hematocrit levels were significantly lower in the hemodialysis group than in the control (p<0.05). Although serum FSH levels were higher and estradiol levels were lower in the hemodialysis group, these differences were not statistically significant (p>0.05). Mean serum LH and prolactin levels were significantly higher in the hemodialysis group compared to the control (p<0.05). No statistically significant difference was noted for endometrial thickness between the groups (p>0.05). Serum LH and prolactin levels were higher and serum FSH, estradiol and TSH levels were lower in patients who developed amenorrhea after hemodialysis treatment when compared to non-amenorrheic subjects. However, these differences were not statistically significant (p>0.05). Discussion: The most important factor in the etiology of menstrual disorders seen in chronic renal failure patients was high serum LH and prolactin levels. Hemodialysis is a successful treatment that extends life expectancy and ameliorates the hypothalamo- pituitary-ovarian axis in chronic renal failure patients.en_US
dc.identifier.citationArıkan, D. C., Bozkurt, S., Arıkan, İ. ve Turgut, E. (2011). Hormone profiles and their relation with menstrual cycles in patients undergoing hemodialysis / Hemodiyaliz hastalarında hormon profilleri ve menstruel siklusla ilişkisi. Turk Jinekoloji ve Obstetrik Dernegi Dergisi.en_US
dc.identifier.endpage39en_US
dc.identifier.issn1305-4252
dc.identifier.issue1en_US
dc.identifier.startpage32en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/4414
dc.identifier.volume8en_US
dc.language.isotren_US
dc.relation.ispartofTurk Jinekoloji ve Obstetrik Dernegi Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY03650
dc.subjectChronic renal failureen_US
dc.subjectHemodialysisen_US
dc.subjectHormone profilesen_US
dc.subjectMenstrual disturbancesen_US
dc.titleHormone profiles and their relation with menstrual cycles in patients undergoing hemodialysisen_US
dc.title.alternativeHemodiyaliz hastalarında hormon profilleri ve menstruel siklusla ilişkisien_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar